Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

GASC1 promotes glioma progression by enhancing NOTCH1 signaling.

Authors:
Zhengzheng Xiao Xiaoli Yang Zebin Liu Zheng Shao Chaojun Song Kun Zhang Xiaobin Wang Zhengwei Li

Mol Med Rep 2021 May 2;23(5). Epub 2021 Mar 2.

Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

Recent studies have reported that gene amplified in squamous cell carcinoma 1 (GASC1) is involved in the progression of several types of cancer. However, whether GASC1 promotes glioma progression remains unknown. Therefore, the present study aimed to investigate the effect of GASC1 exposure on glioma tumorigenesis. The western blot demonstrated that grade III and IV glioma tissues exhibited a higher mRNA and protein expression of GASC1. Moreover, CD133+ U87 or U251 cells from magnetic cell separation exhibited a higher GASC1 expression. Invasion Transwell assay, clonogenic assay and wound healing assay have shown that GASC1 inhibition using a pharmacological inhibitor and specific short hairpin (sh)RNA suppressed the invasive, migratory and tumorsphere forming abilities of primary culture human glioma cells. Furthermore, GASC1‑knockdown decreased notch receptor (Notch) responsive protein hes family bHLH transcription factor 1 (Hes1) signaling. GASC1 inhibition reduced notch receptor 1 (NOTCH1) expression, and a NOTCH1 inhibitor enhanced the effects of GASC1 inhibition on the CD133+ U87 or U251 cell tumorsphere forming ability, while NOTCH1 overexpression abrogated these effects. In addition, the GASC1 inhibitor caffeic acid and/or the NOTCH1 inhibitor DAPT (a γ‑Secretase Inhibitor), efficiently suppressed the human glioma xenograft tumors. Thus, the present results demonstrated the importance of GASC1 in the progression of glioma and identified that GASC1 promotes glioma progression, at least in part, by enhancing NOTCH signaling, suggesting that GASC1/NOTCH1 signaling may be a potential therapeutic target for glioma treatment.

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2021.11949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974312PMC
May 2021

Publication Analysis

Top Keywords

gasc1 inhibition
12
gasc1
12
promotes glioma
12
glioma progression
12
gasc1 promotes
12
glioma
9
u87 u251
8
tumorsphere forming
8
exhibited higher
8
notch receptor
8
notch1 inhibitor
8
human glioma
8
cd133+ u87
8
notch1
5
progression
5
inhibitor
5
receptor notch
4
notch responsive
4
responsive protein
4
clonogenic assay
4

Keyword Occurance

Similar Publications

GASC1 promotes glioma progression by enhancing NOTCH1 signaling.

Authors:
Zhengzheng Xiao Xiaoli Yang Zebin Liu Zheng Shao Chaojun Song Kun Zhang Xiaobin Wang Zhengwei Li

Mol Med Rep 2021 May 2;23(5). Epub 2021 Mar 2.

Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

Recent studies have reported that gene amplified in squamous cell carcinoma 1 (GASC1) is involved in the progression of several types of cancer. However, whether GASC1 promotes glioma progression remains unknown. Therefore, the present study aimed to investigate the effect of GASC1 exposure on glioma tumorigenesis. Read More

View Article and Full-Text PDF
May 2021
Similar Publications

Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.

Authors:
Sara Movassaghian Yuran Xie Claudia Hildebrandt Rayna Rosati Ying Li Na Hyung Kim Denise S Conti Sandro R P da Rocha Zeng-Quan Yang Olivia M Merkel

Mol Pharm 2016 08 27;13(8):2605-21. Epub 2016 Jun 27.

Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.

Basal-like breast cancer (BLBC) accounts for the most aggressive types of breast cancer, marked by high rates of relapse and poor prognoses and with no effective clinical therapy yet. Therefore, investigation of new targets and treatment strategies is more than necessary. Here, we identified a receptor that can be targeted in BLBC for efficient and specific siRNA mediated gene knockdown of therapeutically relevant genes such as the histone demethylase GASC1, which is involved in multiple signaling pathways leading to tumorigenesis. Read More

View Article and Full-Text PDF
August 2016
Similar Publications

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

Authors:
G Liu A Bollig-Fischer B Kreike M J van de Vijver J Abrams S P Ethier Z-Q Yang

Oncogene 2009 Dec 28;28(50):4491-500. Epub 2009 Sep 28.

Department of Pathology, Breast Cancer Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

Earlier, mapping of the 9p23-24 amplicon in esophageal cancer cell lines led us to the positional cloning of gene amplified in squamous cell carcinoma 1 (GASC1), which encodes a nuclear protein with a Jumonji C domain that catalyzes lysine (K) demethylation of histones. However, the transforming roles of GASC1 in breast cancer remain to be determined. In this study, we identified GASC1 as one of the amplified genes for the 9p23-24 region in breast cancer, particularly in basal-like subtypes. Read More

View Article and Full-Text PDF
December 2009
Similar Publications

The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.

Authors:
Paul A C Cloos Jesper Christensen Karl Agger Alessio Maiolica Juri Rappsilber Torben Antal Klaus H Hansen Kristian Helin

Nature 2006 Jul 28;442(7100):307-11. Epub 2006 May 28.

Biotech Research & Innovation Centre, Fruebjergvej 3, 2100 Copenhagen, Denmark.

Methylation of lysine and arginine residues on histone tails affects chromatin structure and gene transcription. Tri- and dimethylation of lysine 9 on histone H3 (H3K9me3/me2) is required for the binding of the repressive protein HP1 and is associated with heterochromatin formation and transcriptional repression in a variety of species. H3K9me3 has long been regarded as a 'permanent' epigenetic mark. Read More

View Article and Full-Text PDF
July 2006
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap